Format

Send to

Choose Destination
See comment in PubMed Commons below
Vaccine. 2006 Jan 23;24(4):495-500. Epub 2005 Aug 15.

Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.

Author information

1
The Department of Pathology and Medicine, University of California-San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093, USA. tkirkland@ucsd.edu

Abstract

Coccidioides immitis is endemic in the soil of the desert Southwest. It causes a respiratory infection that is usually mild, but can last months and may disseminate beyond the lung. Disseminated infections can be fatal or require life-long therapy. Development of an effective vaccine may be a successful method of preventing serious disease. In this paper, we show that immunostimulatory-oligodeoxynucleotides (ISS-ODN) are an effective adjuvant for a recombinant coccidioidal protein known as antigen 2/proline rich antigen. Protective immunity induced by this ISS-ODN-based vaccine requires IL-12, interferon-gamma and MHC Class II-restricted T-cells. Cytotoxic CD8 T-cells are not required. This study elucidates the mechanisms needed to elicit successful immunity against coccidioidomycosis, and holds promise for development of an effective coccidioidal vaccine against coccidioidomycosis.

PMID:
16181709
DOI:
10.1016/j.vaccine.2005.07.092
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center